Characterization of the Dynamics of Hepatitis B Virus Resistance to Adefovir by Ultra-Deep Pyrosequencing

被引:48
|
作者
Rodriguez, Christophe [1 ,2 ]
Chevaliez, Stephane [1 ,2 ]
Bensadoun, Paul [2 ]
Pawlotsky, Jean-Michel [1 ,2 ]
机构
[1] Univ Paris Est, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Hop Henri Mondor, Creteil, France
[2] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France
关键词
INNO-LIPA HBV; INFECTED PATIENTS; THERAPY; IDENTIFICATION; EPIDEMIOLOGY; POPULATIONS; NUCLEOSIDE; LAMIVUDINE; DIPIVOXIL; SELECTION;
D O I
10.1002/hep.26383
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B virus (HBV) resistance to nucleoside/nucleotide analogs is frequent. Ultra-deep pyrosequencing (UDPS) is a powerful new tool that can detect minor viral variants and characterize complex quasispecies mixtures. We used UDPS to analyze the dynamics of adefovir-resistant HBV variants in patients with chronic HBV infection in whom adefovir resistance occurred during treatment. Amino acid substitutions known to confer resistance to adefovir were detected at baseline in most patients. The dynamics of adefovir-resistant variants were complex and differed among patients as a result of evolving differences in variant fitness. UDPS analysis revealed successive waves of selection of HBV populations with single and multiple amino acid substitutions. Adefovir-resistant variants were partially inhibited by lamivudine, but remained fit in its presence. Conclusion: Substitutions conferring HBV resistance to nucleoside/nucleotide analogs exist before treatment, and that the dynamics of adefovir-resistant populations are much more complex and heterogeneous than previously thought and involve thus far unknown amino acid substitutions. The UDPS-based approach described here is likely to have important implications for the assessment of antiviral drug resistance in research and clinical practice. (Hepatology 2013;53:890-901)
引用
收藏
页码:890 / 901
页数:12
相关论文
共 50 条
  • [41] Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection
    Laoi, B. Ni
    Herra, C.
    Norris, S.
    Crowley, B.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 807 - 809
  • [42] EVOLUTION OF HEPATITIS B VIRUS QUASISPECIE IN SERUM SAMPLES BY ULTRA-DEEP PYROSEQUENCING ANALYSIS OF A PATIENT WITH CHB SEQUENTIALLY TREATED WITH DIFFERENT NUCLEOS(T)IDE ANALOGUES
    Rodriguez-Frias, Francisco
    Tabernero, David
    Buti, Mario
    Jardi, Rosendo
    Quer, Josep
    Sanchez, Alex
    Ortega, Israel
    Homs, Maria
    Schaper, Melanie
    Fernandez-Fernandez, Pilar
    Esteban, Rafael
    HEPATOLOGY, 2009, 50 (04) : 517A - 517A
  • [43] Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method
    Ciftci, Sevgi
    Keskin, Fahriye
    Cakiris, Aris
    Akyuz, Filiz
    Pinarbasi, Binnur
    Abaci, Neslihan
    Dincer, Erdinc
    Badur, Selim
    Kaymakoglu, Sabahattin
    Ustek, Duran
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 79 (01) : 25 - 30
  • [44] Evaluation of Persistence of Resistant Variants with Ultra-Deep Pyrosequencing in Chronic Hepatitis C Patients Treated with Telaprevir
    Thomas, Xiomara V.
    de Bruijne, Joep
    Sullivan, James C.
    Kieffer, Tara L.
    Ho, Cynthia K. Y.
    Rebers, Sjoerd P.
    de Vries, Michel
    Reesink, Hendrik W.
    Weegink, Christine J.
    Molenkamp, Richard
    Schinkel, Janke
    PLOS ONE, 2012, 7 (07):
  • [45] Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing
    Huang, Szu-Wei
    Li, Wei-You
    Wang, Wen-Hung
    Lin, Yu-Ting
    Chou, Chih-Hung
    Chen, Marcelo
    Huang, Hsien-Da
    Chen, Yen-Hsu
    Lu, Po-Liang
    Wang, Sheng-Fan
    Oka, Shinichi
    Chen, Yi-Ming Arthur
    PLOS ONE, 2017, 12 (01):
  • [46] A NOVEL HEPATITIS B VIRUS MUTATION WITH RESISTANCE TO ADEFOVIR DIPIVOXIL IN PATIENTS WITH CHRONIC HEPATITIS B
    Liu, L. J.
    Wang, J. H.
    Du, S. C.
    Wei, L.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S334 - S335
  • [47] ANALYSIS OF THE BASIC CORE PROMOTER, PRECORE, AND CORE REGIONS OF HEPATITIS B VIRUS BY ULTRA-DEEP PYROSEQUENCING SHOWS HIGH VARIABILITY IN TATA BOXES AND MAIN EPITOPIC REGIONS
    Homs, Maria
    Buti, Maria
    Tabernero, David
    Jardi, Rosendo
    Quer, Josep
    Comas, Imma
    Ortega, Israel
    Sanchez, Alex
    Esteban, Rafael
    Rodriguez-Frias, Francisco
    HEPATOLOGY, 2011, 54 : 1091A - 1091A
  • [48] Analysis of co-selection of immune escape and treatment- resistant variants in Hepatitis B virus quasispecies by ultra-deep pyrosequencing in lamivudine-treated patients
    Tabernero, David
    Rodriguez-Frias, Francisco
    Casillas, Rosario
    Gregori, Josep
    Quer, Josep
    Mosquera, Marta
    Camos, Silvia
    Ramirez, Clara
    Homs, Maria
    Esteban, Rafael
    Buti, Maria
    HEPATOLOGY, 2012, 56 : 425A - 426A
  • [49] Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)-Treated Patients and NRTI-Naive Patients
    Margeridon-Thermet, Severine
    Shulman, Nancy S.
    Ahmed, Aijaz
    Shahriar, Rajin
    Liu, Tommy
    Wang, Chunlin
    Holmes, Susan P.
    Babrzadeh, Farbod
    Gharizadeh, Baback
    Hanczaruk, Bozena
    Simen, Birgitte B.
    Egholm, Michael
    Shafer, Robert W.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (09): : 1275 - 1285
  • [50] Analysis of Ultra-Deep Pyrosequencing and Cloning Based Sequencing of the Basic Core Promoter/Precore/Core Region of Hepatitis B Virus Using Newly Developed Bioinformatics Tools
    Yousif, Mukhlid
    Bell, Trevor G.
    Mudawi, Hatim
    Glebe, Dieter
    Kramvis, Anna
    PLOS ONE, 2014, 9 (04):